Wnt glycoproteins regulate homeostasis and development by binding to membrane Frizzled-LRP5/6 receptor complexes. Wnt signaling includes a canonical pathway involving cytosolic b-catenin stabilization, nuclear translocation and gene regulation, acting as a co-activator of T-cell factor (TCF) proteins, and noncanonical pathways that activate Rho, Rac, JNK and PKC, or modulate Ca 2 þ levels. DICKKOPF-1 (DKK-1) encodes a secreted Wnt antagonist that binds to LRP5/6 and induces its endocytosis, leading to inhibition of the canonical pathway. We show that activation of canonical signaling by Wnt1 or ectopic expression of active b-catenin, TCF4 or LRP6 mutants induces transcription of the human DKK-1 gene. Multiple b-catenin/TCF4 sites in the DKK-1 gene promoter contribute to this activation. In contrast, Wnt5a, which signals through noncanonical pathways, does not activate DKK-1. Northern and Western blot studies show that activation of the Wnt/b-catenin pathway by treatment with lithium or Wnt3a-conditioned medium, or by stable expression of either Wnt1 or b-catenin, increases DKK-1 RNA and protein, thus initiating a negative feedback loop. However, we found that DKK-1 expression decreases in human colon tumors, which suggests that DKK-1 acts as a tumor suppressor gene in this neoplasia. Our data indicate that the Wnt/b-catenin pathway is downregulated by the induction of DKK-1 expression, a mechanism that is lost in colon cancer. Keywords: Wnt; DICKKOPF-1; b-catenin; T-cell factor 4; gene regulation
The family of Wnt glycoproteins includes 19 members in humans that regulate development and homeostasis.
They bind to Frizzled receptors and LRP5/6 co-receptors located at the plasma membrane and signal through canonical and noncanonical pathways (Miller, 2002; Giles et al., 2003) . Canonical signaling causes accumulation of b-catenin in the cytosol through inhibition of its proteasome-targeting phosphorylation by glycogen synthase kinase-3b, which forms a complex with the tumor suppressor adenomatous polyposis coli (APC) and Axin proteins. This is followed by translocation to the nucleus, where b-catenin associates with DNA-bound T-cell factors (TCFs) and thus regulates gene expression. Early activation of this pathway by mutation in APC or b-catenin occurs in most human colon cancers and a proportion of other carcinomas. Noncanonical pathways lead to the activation of the small GTPases Rho and Rac, or kinases such as JNK and PKC, or to changes in the levels of Ca 2 þ (Miller, 2002) .
Several natural Wnt antagonists are known, including members of the Dickkopf (Dkk) family (Zorn, 2001; Kawano and Kypta, 2003) . Dkk-1 is a secreted protein that binds to LRP5/6 and Kremen proteins, thus inducing LRP endocytosis which prevents the formation of Wnt-Frizzled-LRP5/6 receptor complexes and blocks canonical Wnt signaling is induced by Wnt signalling during mid blastula transition (Bafico et al., 2001; Mao et al., 2001 Mao et al., , 2002 Semenov et al., 2001) . Dkk-1 is important for normal head development in Xenopus and mice (Glinka et al., 1998) . In the small intestine, activation of b-catenin transcriptional activity leads to changes in the pattern of gene expression that impose a dedifferentiated proliferative progenitor cell phenotype (van de Wetering et al., 2002) , while forced Dkk-1 expression inhibits cell proliferation and the generation of secretory lineages (Pinto et al., 2003; Kuhnert et al., 2004) . Moreover, DKK-1 seems to induce the proliferation of human adult bone marrow stem cells (Gregory et al., 2003) and contribute to the control of osteoporosis, as mutations in LRP5 that impede binding of DKK-1 are responsible for high bone density (Boyden et al., 2002) . DKK-1 also inhibits osteoblastic differentiation and high circulating levels of DKK-1 in patients with multiple myeloma are associated with osteolytic lesions (Tian et al., 2003) .
However, in spite of the multiple biological roles of Dkk-1, little is known about the control of its expression. Human DKK-1 was reported to be responsive to p53 (Wang et al., 2000) , although it has been shown to be induced by DNA damage and to sensitize to apoptosis in a p53-independent manner (Shou et al., Roessler et al. (2000) . Sequence analysis using Matinspector computer software (Genomatix) predicted nine putative TCF4-binding sites, which are shown as gray boxes. 293T cells were transfected with each promoter construct (100 ng) and the activity was measured in the absence and in the presence of cotransfected TCF4-VP16-expressing plasmid (20 ng). Fold increase was then calculated for each construct and reported as a percentage of the fold increase shown by the À2.2 kb construct, which had the highest transcriptional activity
. Recently, glucocorticoids have been reported to enhance DKK-1 expression in human osteoblasts (Ohnaka et al., 2004) .
Sequence analysis of the human DKK-1 gene promoter (NCBI database) revealed nine putative TCFbinding sites: three located near the transcription initiation site, four in the -920/À580 bp region and two further upstream (Supplementary Material on-line). To examine the regulation of the DKK-1 gene we cloned a 2350 bp fragment of its upstream region containing the nine putative TCF-binding sites (Figure 1 and Supplementary Material). We first analysed the effect of TCF4-VP16, a constitutively active version of TCF4. TCF4-VP16 caused dose-dependent activation of the DKK-1 gene promoter, comparable to but lower than that of the TOPflash plasmid containing three consensus TCF sites in tandem (Figure 1a) . Stimulation of DKK-1 gene promoter by TCF4-VP16 was detected in several human epithelial cells of different origin (MCF-7, MDA-MB-453, HeLa) (not shown). Supporting a role of cytosolic b-catenin accumulation in the regulation of DKK-1 gene promoter, co-transfection of increasing amounts of a bcatenin expression vector caused dose-dependent activation of up to ninefold (Figure 1b) . In addition, a mutant nondegradable b-catenin lacking a phosphorylation site (S37Y) efficiently activated the DKK-1 promoter (Figure 1c) . The specificity of b-catenin acting through TCF sites was analysed using DTCF4, a mutant form of TCF4 unable to bind b-catenin that acts as a constitutive transcriptional repressor. DTCF4 abolished the activation of the DKK-1 promoter by b-catenin, and also decreased the basal level of promoter activity in 293T cells (Figure 1d) .
The role of the various TCF sites was also examined. A series of deletion constructs were made and their response to TCF4-VP16 was analysed in 293T cells (Figure 1e ). Our results indicate that the clusters of three TCF sites placed respectively close to the initiation site (À198/À107) and in the À909/À822 region contribute most to this response.
We also examined whether Wnt proteins that signal through the canonical b-catenin (Wnt1) or noncanonical pathways (Wnt5a) induce the DKK-1 gene promoter. We co-cultured Rat2 cells stably expressing either Wnt1 or Wnt5a mouse genes together with 293T cells transiently transfected with the DKK-1 promoter. Coculture with Wnt1-expressing cells, but not with those expressing Wnt5a or an empty vector, led to the activation of the human DKK-1 gene promoter ( Figure 2a ). As expected, the same result was obtained with the b-catenin/TCF consensus TOPflash reporter plasmid (Figure 2a) . To ensure the specificity of Wnt1 action, we used an expression vector for DKK-1, which antagonizes Wnt/b-catenin signaling. Thus, the activating effect of Wnt1-expressing cells on human DKK-1 promoter was inhibited in the presence of co-transfected DKK-1 (Figure 2b) , showing that secreted DKK-1 protein can block transcription from its own promoter by negative feedback. To confirm that this effect of DKK-1 was mediated by its LRP-binding activity, we transfected 293T cells with a plasmid encoding a constitutively active LRP6 protein (DN-LRP6) that lacks the extracellular region and so does not bind DKK-1 . As observed for the TOPflash plasmid, co-transfection of DN-LRP6 activated the human DKK-1 gene promoter, and cotransfected DKK-1 did not inhibit this effect (Figure 2c ). Concordantly with the activation of the promoter, endogenous DKK-1 RNA and protein are upregulated in response to Wnt/b-catenin activation. Lithium, an inhibitor of glycogen synthase kinase-3b, which initiates downstream signaling, induces the accumulation of DKK-1 RNA in both 293 and HeLa cells (Figure 3a , upper panels). The kinetics of induction correlates with the increase of b-catenin levels in the cytosol (Figure 3a , lower panels). Moreover, treatment of HeLa cells with Wnt3a-conditioned medium but not control medium led to an increase in DKK-1 RNA (Figure 3b, upper panel) . Like Wnt1, Wnt3a activates the canonical pathway, which can be monitored by the accumulation of cytosolic b-catenin (Figure 3b, lower panel) . To confirm these data, we generated HeLa cells stably expressing Wnt1 or b-catenin (S37Y) and also 293 cells stably expressing b-catenin (S37Y). Expression of DKK-1 RNA was higher in these cells than in controls, which correlates with an increase in cytosolic b-catenin levels (Figure 3c and d, and data not shown). Higher levels of DKK-1 RNA in Wnt1-expressing cells correlate with augmented DKK-1 protein (Figure 3d ).
Taken together, our data show that the human DKK-1 gene is induced by an active Wnt/b-catenin signaling pathway in human cells. Analogously, zebrafish DKK-1 is induced by Wnt signaling during midblastula transition (Shinya et al., 2000) . Upregulation of this Wnt inhibitor creates a negative feedback (Figure 3e ), similar to that described for TCF1 (Roose et al., 1999) , bTrCP ubiquitin ligase (Spiegelman et al., 2000) , axin2 or hnkd (Lustig et al., 2001; Yan et al., 2001) . Since the Wnt/b-catenin pathway is activated in most human colon cancers as a result of APC loss and mutation or, less frequently, b-catenin mutation (Giles et al., 2003) , we analysed DKK-1 expression in 32 pairs of human colon tumoral (T) and normal (N) tissue biopsies. Quantitative RT-PCR studies including c-MYC as a bcatenin/TCF4-induced gene and two housekeeping genes as controls showed that, unexpectedly, DKK-1 was downregulated in colon tumors as compared to normal tissue (18/32) (Figure 4, upper panel) . In contrast c-MYC was overexpressed (24/32) (Figure 4,  lower panel) . A plausible explanation is that DKK-1 is induced by Wnt signals as a component of a negative feedback loop in normal tissues, but in colorectal cancer this autoregulatory mechanism might be lost or abolished by other superimposed mechanisms, for example, promoter hypermethylation or loss of heterozygosity, leading to DKK-1 silencing. Consequently, despite high TCF/b-catenin transcriptional activity, DKK-1 transcription is constitutively switched off. Such silencing mechanisms have been reported for other extracellular for the indicated times. Total RNA was prepared using the RNeasy Kit (Qiagen). Cytosolic protein samples were prepared as described previously . Northern blots were performed according to standard protocols (Sambrook et al., 1989) . The DKK-1 probe, a 0.5-kb HindIII fragment, was labeled by the random priming method (Feinberg and Vogelstein, 1983) . Hybridizations were carried out overnight at 421C using ULTRAhyb R hybridization buffer (Ambion). Methylene blue staining of 28S rRNA is shown as loading control. Western blots of cytosolic fractions were probed with antibodies against b-catenin (1 : 1000; Transduction Laboratories) and b-tubulin (1 :40 000; Sigma), as a control. (b) Wnt3a signaling triggers the accumulation of DKK-1 RNA. HeLa cells were treated with either control (À) or Wnt3a-conditioned ( þ ) medium for the indicated times. RNA and protein samples were obtained as in (a) and Northern (upper panels) and Western (lower panels) blots analysing DKK-1 expression and cytosolic b-catenin, respectively, were performed. (c) Permanent activation of canonical Wnt signaling increases DKK-1 RNA levels in 293 cells. Cells were stably transfected with a b-catenin (S37Y) expression plasmid. Northern and Western blots analysing DKK-1 expression (upper panel) and cytosolic b-catenin (lower panel), respectively, were performed as described above. (d) Wnt1 increases DKK-1 RNA and protein in HeLa cells. Cells were stably transfected with a Wnt1 expression construct and DKK-1 RNA and protein levels were measured by Northern (upper panels) and Western (lower panels) blot analyses as described above. A goat anti-DKK-1 antibody (1 : 50; Santa Cruz Biotechnology) was used. (e) Scheme of the feedback mechanism of autoregulation of the Wnt/b-catenin pathway through the activation of DKK-1 Wnt inhibitors. Thus, expression of several members of the secreted Frizzled-related proteins (SFRP) family is inhibited in numerous colorectal cancers by promoter hypermethylation (Suzuki et al., 2002 (Suzuki et al., , 2004 Caldwell et al., 2004) . In addition, the expression of extracellular Wnt inhibitor factor-1 (WIF-1) is silenced by promoter hypermethylation in human lung cancer . Moreover, DKK-3, another member of the Dickkopf family, is also downregulated in non-smallcell lung cancer and acute lymphoblastic leukemia by promoter methylation (Kobayashi et al., 2002; RomanGo´mez et al., 2004) . Further studies should investigate the status of DKK-1 in colorectal tumors. Nevertheless, our data indicate that DKK-1 may act as a tumor suppressor gene in colon cancer, and contrasts with the overexpression of DKK-1 reported in human hepatoblastomas and Wilms' tumors (Wirths et al., 2003) . DKK-1 loss may promote colon cancer progression by increasing the expression of b-catenin/TCF target genes. It remains to be determined whether extracellular DKK-1 exerts a suppressive effect, given that the pathway is disregulated in this neoplasia as a result of APC or bcatenin mutations that disconnect the downstream cascade from the Wnt receptors. In this regard, recent evidence has shown that restoration of SFRP function in colorectal cancer cells attenuates Wnt signaling even in the presence of downstream mutations (Suzuki et al., 2004) . Thus, DKK-1 may have additional tumorsuppressive effects not linked to the inhibition of canonical b-catenin signaling, as described in human HeLa (Mikheev et al., 2004) and mesothelioma cells . The relative concentrations of the target and the reference genes was calculated by interpolation on a standard curve of each gene generated with a serial dilution of cDNA obtained from MCF-7 cells. For first-strand cDNA synthesis, total RNA (400 ng) was retro-transcribed using the Gold RNA PCR Core Kit (AB Biosystems) following the manufacturer's instructions using random hexamers as primers. The reaction was performed in a Light-Cycler apparatus using the LightCyclerFastStart DNA MasterPLUS SYBR Green I Kit (Roche Diagnostics, Mannheim, Germany). Each reaction was carried out in a final volume of 20 ml containing 2 ml of the cDNA product sample, 0.5 mM of each primer and 1 Â reaction mix including FastStar DNA polymerase, reaction buffer, dNTPs and SYBR green. Thermal cycling for all genes was initiated with a denaturation step of 951C for 10 min and consisted of 40 cycles (denaturation at 941C for 0 s, annealing at 591C for 5 s, and elongation at 721C for 5 s). At the end of the PCR cycles, melting curve analyses and electrophoresis of the products on nondenaturing 8% polyacrylamide gels were performed to ensure the generation of the expected PCR product. Patients (23 males and nine females) had a median age of 71 years, range 49-86 years. The tumor was located on the left side in 20 patients and rightsided in the rest. The distribution by histological grade was as follows: 18 tumors in grade I and 14 in grade II. No cases were observed in grade III. Lymph node metastases were found in 14 patients. Staging: four patients were in stage I, 13 in stage II and 15 in advanced stages (11 in stage III, and four in stage IV). Vascular invasion was observed in 16 tumors b-catenin induces DKK-1 expression JM González-Sancho et al
